Thus, our study suggests that post-translational modification of p53 by acetylation may be an important novel regulatory mechanism for enhancing p53 stability and activation following cerebral ischemia, leading to enhanced apoptotic cell death. The gene discussed is TP53; the disease is brain ischemia.